Clearance Summary
CeQur Simplicity On-Demand Insulin Delivery System received FDA 510(k) clearance under submission number K252757, sponsored by Cequr SA. The device was reviewed via the Special premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 2026-04-10.
- Submission: K252757
- Applicant / Sponsor: Cequr SA
- Clearance pathway: Special
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5725
- Decision date: 2026-04-10
Classification & Regulation
This clearance is catalogued under FDA product code OPP and 21 CFR 880.5725, within the General Hospital review panel as a Class II device.